KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInvestment IncomeNet Income - MinorityNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Sabra Health Care REIT (SBRA) Net Income towards Common Stockholders (2016 - 2025)

Sabra Health Care REIT (SBRA) has 14 years of Net Income towards Common Stockholders data on record, last reported at $23.5 million in Q4 2025.

  • For Q4 2025, Net Income towards Common Stockholders fell 49.67% year-over-year to $23.5 million; the TTM value through Dec 2025 reached $147.6 million, up 16.13%, while the annual FY2025 figure was $149.6 million, 17.72% up from the prior year.
  • Net Income towards Common Stockholders reached $23.5 million in Q4 2025 per SBRA's latest filing, up from $19.3 million in the prior quarter.
  • Across five years, Net Income towards Common Stockholders topped out at $64.7 million in Q2 2025 and bottomed at -$14.5 million in Q3 2023.
  • Average Net Income towards Common Stockholders over 5 years is $24.1 million, with a median of $23.7 million recorded in 2024.
  • Peak YoY movement for Net Income towards Common Stockholders: crashed 129.88% in 2021, then surged 410.43% in 2024.
  • A 5-year view of Net Income towards Common Stockholders shows it stood at -$11.1 million in 2021, then soared by 274.35% to $19.3 million in 2022, then fell by 7.33% to $17.9 million in 2023, then skyrocketed by 161.15% to $46.8 million in 2024, then tumbled by 49.67% to $23.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for Net Income towards Common Stockholders were $23.5 million in Q4 2025, $19.3 million in Q3 2025, and $64.7 million in Q2 2025.